Special Issue "Novel Medical Approach to Diagnostic and Therapeutic Algorithms in Ophthalmology"

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".

Deadline for manuscript submissions: 15 December 2021.

Special Issue Editor

Prof. Dr. Edward Wylegala
E-Mail Website
Guest Editor
Chair and Clinical Department of Ophthalmology, Faculty of Medical Science Division in Zabrze, Medical University of Silesia, Katowice, Poland

Special Issue Information

Dear Colleagues,

There is a broad spectrum of new developments in ophthalmology every year. Not all elements of these developments contribute to changes in clinical procedures in ophthalmology. The aim of this Special Issue is to try to focus on those tools that have a chance to be implemented in new diagnostic and therapeutic algorithms. Increasingly, an ophthalmologist must use many fields of medicine, combine areas of knowledge and use tools that previously seemed distant from everyday clinical work. Genetic research, artificial intelligence, new imaging methods, and biomarkers are more and more often very helpful, but they require one to significantly expand our knowledge. The articles in this Special Issue are intended to help to implement novel methods for everyday clinical approaches to diagnostics and treatment in different areas of ophthalmology.

Prof. Dr. Edward Wylegala
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • corneal transplants
  • stem cell therapy
  • MIGS
  • premium IOL lenses
  • laser surgery
  • deep phenotyping
  • PPV
  • macular edema
  • uveitis
  • AMD

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Article
Retinal OCT Findings in Patients after COVID Infection
J. Clin. Med. 2021, 10(15), 3233; https://doi.org/10.3390/jcm10153233 - 22 Jul 2021
Viewed by 262
Abstract
Purpose: The aim of this study was to assess and compare the optic nerve, retina, and retinal vessel parameters in recovered COVID-19 patients and healthy patients by using optical coherence tomography angiography (OCT-a). Methods: In all, 156 eyes of post-COVID-19 patients and 98 [...] Read more.
Purpose: The aim of this study was to assess and compare the optic nerve, retina, and retinal vessel parameters in recovered COVID-19 patients and healthy patients by using optical coherence tomography angiography (OCT-a). Methods: In all, 156 eyes of post-COVID-19 patients and 98 eyes of subjects from a control group were enrolled in our study. BCVA, intra ocular pressure (IOP) measurement, fundus examination, and OCT images, including macular cube, OCT-RNFL, and angio-OCT 6 × 6 mm examinations, were performed for both groups. The measurements were acquired using Swept Source OCT DRI OCT Triton. In the post-COVID-19 group, 762 OCT protocols were obtained. For statistical analysis, parameters from only one eye from each subject were taken. Results: In the measured parameters, no significant differences were observed, i.e., central macular thickness (p = 0.249); RNFL (p = 0.104); FAZ (p = 0.63); and vessel density of superficial retinal vascular plexus in central (p = 0.799), superior (p = 0.767), inferior (p = 0.526), nasal (p = 0.402), and temporal (p = 0.582) quadrants. Furthermore, a slit-lamp examination did not reveal any COVID-19-related abnormalities. Conclusion: OCT examination did not detect any significant changes in morphology or morphometry of the optic nerve, retina, or the retina vessels due to COVID-19. Full article
Show Figures

Figure 1

Article
A Retrospective Study of Herpetic Keratitis in Patients with Keratoconus after Crosslinking Surgery
J. Clin. Med. 2021, 10(12), 2684; https://doi.org/10.3390/jcm10122684 - 18 Jun 2021
Viewed by 266
Abstract
Background: The aim of this study was to perform a retrospective analysis of patients who underwent cross-linking for keratoconus, in the Department of Ophthalmology of the Medical University of Silesia in Katowice, between 2011 and 2020, regarding the occurrence of herpetic keratitis after [...] Read more.
Background: The aim of this study was to perform a retrospective analysis of patients who underwent cross-linking for keratoconus, in the Department of Ophthalmology of the Medical University of Silesia in Katowice, between 2011 and 2020, regarding the occurrence of herpetic keratitis after the procedure. Methods: We analyzed the medical history of 543 patients who underwent cross-linking surgery. Results: In the analyzed group, there were nine cases of herpetic keratitis (six men and three women), aged from 16 to 40 years (mean 26.2 years). The mean follow-up period was 49.3 months (16–82 months). The average time from surgery to the manifestation of the first symptoms of keratitis was 4.3 days (2–6 days). In two cases, iritis was observed, and in one of them, iritis was the first symptom. After systemic and topical administration of acyclovir, ulceration healed in all patients. Corneal healing time ranged from 10 days to 3 weeks (average 13.7 days). In one patient, a recurrence of the inflammation was observed after 8 months. Conclusion: Patients should be carefully observed in the early post-CXL period. Herpetic keratitis could be induced by CXL even in patients with no history of herpetic disease. Full article
Show Figures

Figure 1

Article
Iris-Claw Intraocular Lens Implantation in Various Clinical Indications: A 4-Year Study
J. Clin. Med. 2021, 10(6), 1199; https://doi.org/10.3390/jcm10061199 - 13 Mar 2021
Cited by 1 | Viewed by 540
Abstract
An iris-claw intraocular lens (IOL) has been widely used as a secondary implant in aphakic patients. The study presents the results of implanting the anterior chamber iris-claw Artisan IOL in cases of where an appropriate posterior capsular support is lacking. The study included [...] Read more.
An iris-claw intraocular lens (IOL) has been widely used as a secondary implant in aphakic patients. The study presents the results of implanting the anterior chamber iris-claw Artisan IOL in cases of where an appropriate posterior capsular support is lacking. The study included 132 patients subjected to primary IOL implantation during complicated cataract surgery with damage to the posterior capsule (I), secondary implantation in aphakia (II), secondary implantation during penetrating keratoplasty (III), and secondary implantation during pars plana vitrectomy with luxated IOL extraction (IV). We analyzed the records of best-corrected visual acuity (BCVA), spherical equivalent (SE), intraocular pressure (IOP), and corneal endothelial cell count (cECC), taken before and 1, 2, 3, and 4 years after the surgery. BCVA depended on the time after IOL implantation and the primary indication. Four years post-surgery, the SE values were the lowest in group III. IOP was the same in all groups both before and after the surgery, but 4 years after the surgery IOP values in group IV were higher than in group III. The cECC decreased every year after the surgery in all groups, but four years after the IOL implantation, the lowest cECC values were observed in group IV. At the same time, all groups of patients showed improved BCVA, stable refraction, and a low percentage of postoperative complications. Full article
Show Figures

Figure 1

Back to TopTop